Why Hurry Up and Wait? Transplantation in Lower-Risk Myelodysplastic Syndromes

Biol Blood Marrow Transplant. 2020 Nov;26(11):e263-e264. doi: 10.1016/j.bbmt.2020.09.012. Epub 2020 Sep 19.

Authors

Tania Jain¹, Amy E DeZern²

Affiliations

¹ Division of Hematological Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.
² Division of Hematological Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland. Electronic address: Adezern1@jhmi.edu.

PMID: 32961368
DOI: 10.1016/j.bbmt.2020.09.012

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Myelodysplastic Syndromes* / therapy
Transplantation Conditioning